Ожирение - Страница 60

training

fails to affect 24-hour energy expenditure in weight-stable, post-obese

women. Int. J. Obes. 1992 16 809-816.

69. Burstein R; Epstein Y; Charuzi I; Suessholz A; Karnieli E; Shapiro Y

Glucose utilization in morbidly obese subjects before and after weight loss

by gastric bypass operation. Int J Obes Relat Metab Disord 1995

Aug;19(8):558-61

70. Buzzard L. M., Asp E. H., Chlebowsski R. T. et al. Diet intervention

methods to reduce fat intake: nutrient and food group composition of

self-selected low-fat diets. J. Am Diet. Assoc. 1990 90 42-53.

71. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass

index and mortality in a prospective cohort of U.S. adults. N Engl J Med

1999 Oct 7;341(15):1097-105

72. Campbell D.B. Dexfenfluramine: an overview of its mechanisms of

action. Rev. Contemp. Pharmacother. 1991. Vol. 2., N2. - P. 93-113

73. Campbell LV A change of paradigm: obesity is not due to either

`excess` energy intake or `inadequate` energy expenditure. Int J Obes Relat

Metab Disord 1998 Nov;22(11):1137

74. Campfield LA; Smith FJ; Mackie G; Tenenbaum R; Sassano ML; Mullin J;

Kaiser K; Kierstead RW Insulin normalization as an approach to the

pharmacological treatment of obesity. Obes Res 1995 Nov;3 Suppl 4:591S-603S

75. Carmichael A. R. Treatment for morbid obesity. Postgrad Med J 1999

Jan;75(879):7-12

76. Carmody TP, Brunner RL, St Jeor ST Hostility, dieting, and nutrition

attitudes in overweight and weight-cycling men and women. Int J Eat Disord

1999 Jul;26(1):37-42

77. Caro JF; Kolaczynski JW; Nyce MR; Ohannesian JP; Opentanova I;

Goldman WH; Lynn RB; Zhang PL; Sinha MK; Considine RV Decreased

cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for

leptin resistance. Lancet 1996 Jul 20;348(9021):159-61

78. Casanueva FF, Dieguez C Neuroendocrine regulation and actions of

leptin. Front Neuroendocrinol 1999 Oct;20(4):317-63

79. Chen M Observation of curative effect of lipid lowering and fat

restraining tablets on complicated obesity. J Tradit Chin Med 1995

Dec;15(4):252-5

80. Chitwood LF; Brown SP; Lundy MJ; Dupper MA Metabolic propensity

toward obesity in black vs white females: responses during rest, exercise

and recovery. Int J Obes Relat Metab Disord 1996 May;20(5):455-62

81. Chow WH; McLaughlin JK; Mandel JS; Wacholder S; Niwa S; Fraumeni JF

Jr Obesity and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev

1996 Jan;5(1):17-21

82. Coli P; Pea E; Lacorte M; Passaglia C; Carrai M Valutazione (a breve

termine) del comportamento degli indici antropometrici e dei parametri

bioumorali in soggetti obesi trattati con acarbosio. Minerva Med 1996

Apr;87(4):161-70

83. Considine RV; Considine EL; Williams CJ; Hyde TM; Caro JF The

hypothalamic leptin receptor in humans: identification of incidental

sequence polymorphisms and absence of the db/db mouse and fa/fa rat

mutations. Diabetes 1996 Jul;45(7):992-4

84. Corona Muniz I; Camacho Hernandez R; Escobedo de la Pena J Оbesidad,

distribucion central de la grasa corporal y cardiopatia isquemica en

poblacion mexicana. Arch Inst Cardiol Mex 1996 Mar-Apr;66(2):143-50

85. De Pue JD; Clark MM; Ruggiero L; Medeiros ML; Pera V Jr Maintenance

of weight loss: a needs assessment. Obes Res 1995 May;3(3):241-8

86. DeFronzo R.A., Ferrannini E. Insulin resistance, a multifaceted

syndrome responsible for NIDDM, obesity, hypertension, dislipidemia and

atherosclerotic cardiovascular disease. // Diabetes Care. - 1991. - V.4.,

N.3. - P. 173-194.

87. Desaive C A critical review of a personal series of 1000

gastroplasties. Int J Obes Relat Metab Disord 1995 Sep;19 Suppl 3:S56-60

88. Despres J.P., Moorjani S., Lupien P.J. et.al., Regional distribution

of body fat, plasma lipoproteins, and